Linked Life Data

6811933

Source:http://linkedlifedata.com/resource/pubmed/id/6811933

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1982-12-2
pubmed:abstractText
Animal research reveals that cocaine is a highly reinforcing drug, and patients describe it as "compelling"; the drug maintains vigorous self-administration behavior in animals and humans despite its clear adverse effects. This suggests that the drug is very difficult for experienced users to give up. It further suggests a need for vigorous treatment to produce and maintain abstinence, thus permitting patients to relearn drug-free behaviors which are alternative to continued cocaine use. This 12-month pilot study aimed to determine 1) whether cocaine abusers would enter and remain in treatment, and 2) whether contingency contracts appear to complement standard clinical treatment in initiating and maintaining abstinence. We established cocaine clinics in Denver and Aspen. Of the first 67 patients admitted into those clinics, 32 (48 percent) elected to utilize contingency contracts. Thirty-one of those completely abstained from cocaine use during the treatment. Of the 35 patients who did not elect to use contingency contracts, no one remained abstinent and in treatment for more than four weeks. The results indicate that cocaine abusers will enter treatment, and that contingency contracting may contribute to a favorable outcome.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1046-9516
pubmed:author
pubmed:issnType
Print
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
452-9
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
Use of contingency contracts in specialty clinics for cocaine abuse.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Case Reports